Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226).

Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226). Ophthalmology. 2018 10; 125(10):e70-e71.

View in: PubMed

subject areas

Bevacizumab
Fluoresceins
Follow-Up Studies
Humans
Infant, Newborn
Intravitreal Injections
Retinopathy of Prematurity

authors with profiles

Sarah Rodriguez
Michael P Blair